Steffi Herold

2.2k total citations
22 papers, 1.6k citations indexed

About

Steffi Herold is a scholar working on Molecular Biology, Oncology and Neurology. According to data from OpenAlex, Steffi Herold has authored 22 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Neurology. Recurrent topics in Steffi Herold's work include Ubiquitin and proteasome pathways (6 papers), Neuroblastoma Research and Treatments (5 papers) and Cancer-related Molecular Pathways (5 papers). Steffi Herold is often cited by papers focused on Ubiquitin and proteasome pathways (6 papers), Neuroblastoma Research and Treatments (5 papers) and Cancer-related Molecular Pathways (5 papers). Steffi Herold collaborates with scholars based in Germany, United Kingdom and United States. Steffi Herold's co-authors include Martin Eilers, Michael Wanzel, Barbara Herkert, Susanne Walz, Elmar Wolf, Vincent Beuger, Juhani E. Syväoja, Hanspeter Saluz, Owen J. Sansom and Nikita Popov and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Journal of Experimental Medicine.

In The Last Decade

Steffi Herold

21 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steffi Herold Germany 16 1.4k 486 267 171 154 22 1.6k
Jana Karásková Canada 17 870 0.6× 379 0.8× 333 1.2× 116 0.7× 104 0.7× 22 1.4k
Peter J. Hurlin United States 27 1.6k 1.1× 580 1.2× 296 1.1× 181 1.1× 166 1.1× 47 2.0k
Margareta Wilhelm Sweden 19 1.1k 0.8× 703 1.4× 340 1.3× 106 0.6× 126 0.8× 30 1.4k
Micaela Quarto Italy 16 1.5k 1.1× 773 1.6× 318 1.2× 159 0.9× 204 1.3× 18 1.9k
Natalie Meyer Canada 5 1.2k 0.8× 351 0.7× 337 1.3× 106 0.6× 108 0.7× 7 1.5k
Wouter Nijkamp Netherlands 8 1.3k 1.0× 401 0.8× 264 1.0× 65 0.4× 75 0.5× 9 1.6k
Andrea Cocito Italy 9 2.0k 1.5× 683 1.4× 332 1.2× 274 1.6× 130 0.8× 11 2.3k
Abha Saxena India 15 754 0.5× 282 0.6× 341 1.3× 100 0.6× 96 0.6× 32 1.3k
Anthony C. Liang United States 14 1.4k 1.0× 495 1.0× 356 1.3× 187 1.1× 189 1.2× 22 1.9k
Brenda O’Connell United States 15 1.4k 1.0× 480 1.0× 292 1.1× 182 1.1× 168 1.1× 21 1.7k

Countries citing papers authored by Steffi Herold

Since Specialization
Citations

This map shows the geographic impact of Steffi Herold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steffi Herold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steffi Herold more than expected).

Fields of papers citing papers by Steffi Herold

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steffi Herold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steffi Herold. The network helps show where Steffi Herold may publish in the future.

Co-authorship network of co-authors of Steffi Herold

This figure shows the co-authorship network connecting the top 25 collaborators of Steffi Herold. A scholar is included among the top collaborators of Steffi Herold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steffi Herold. Steffi Herold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gallant, Peter, Mareike Müller, Steffi Herold, et al.. (2025). The USP11/TCEAL1 complex promotes transcription elongation to sustain oncogenic gene expression in neuroblastoma. Genes & Development. 39(11-12). 751–769.
2.
3.
Papadopoulos, Dimitrios, Apoorva Baluapuri, Theresa Endres, et al.. (2021). MYCN recruits the nuclear exosome complex to RNA polymerase II to prevent transcription-replication conflicts. Molecular Cell. 82(1). 159–176.e12. 27 indexed citations
4.
Herold, Steffi, Gabriele Büchel, Carsten P. Ade, et al.. (2019). Recruitment of BRCA1 limits MYCN-driven accumulation of stalled RNA polymerase. Nature. 567(7749). 545–549. 68 indexed citations
5.
Dejure, Francesca R., Steffi Herold, Susanne Walz, et al.. (2017). The MYC mRNA 3′‐UTR couples RNA polymerase II function to glutamine and ribonucleotide levels. The EMBO Journal. 36(13). 1854–1868. 52 indexed citations
6.
Büchel, Gabriele, Anne Carstensen, Eoin Leen, et al.. (2017). Association with Aurora-A Controls N-MYC-Dependent Promoter Escape and Pause Release of RNA Polymerase II during the Cell Cycle. Cell Reports. 21(12). 3483–3497. 60 indexed citations
7.
Wiegering, Armin, Thomas Jamieson, Melanie Hüttenrauch, et al.. (2015). Targeting Translation Initiation Bypasses Signaling Crosstalk Mechanisms That Maintain High MYC Levels in Colorectal Cancer. Cancer Discovery. 5(7). 768–781. 84 indexed citations
8.
Walz, Susanne, Francesca Lorenzin, Jennifer P. Morton, et al.. (2014). Activation and repression by oncogenic MYC shape tumour-specific gene expression profiles. Nature. 511(7510). 483–487. 348 indexed citations
9.
Nowaczyk, Piotr, Steffi Herold, Annette Schmitz, et al.. (2012). 61 Functionalized and Structured Medical Wire as a Device for In-vivo Isolation of Circulating Tumor Cells in Breast Cancer Patients. European Journal of Cancer. 48. S58–S59. 1 indexed citations
10.
Kaiser, Andreas, Steffi Herold, Stefan G. Lechner, et al.. (2011). The human papillomavirus type 16 E7 oncoprotein targets Myc-interacting zinc-finger protein-1. Virology. 422(2). 242–253. 10 indexed citations
11.
Heyden, Alexandra, T. B. Tomasi, Steffi Herold, et al.. (2011). PP 45 In vivo isolation of circulating tumor cells. European Journal of Cancer. 47. S19–S19. 1 indexed citations
12.
Herkert, Barbara, Steffi Herold, Mona Abed, et al.. (2010). The Arf tumor suppressor protein inhibits Miz1 to suppress cell adhesion and induce apoptosis. The Journal of Cell Biology. 188(6). 905–918. 33 indexed citations
13.
Iraci, Nunzio, Daniel Diolaiti, Antonella Papa, et al.. (2010). A SP1/MIZ1/MYCN Repression Complex Recruits HDAC1 at theTRKAandp75NTRPromoters and Affects Neuroblastoma Malignancy by Inhibiting the Cell Response to NGF. Cancer Research. 71(2). 404–412. 70 indexed citations
14.
Herold, Steffi, Barbara Herkert, & Martin Eilers. (2009). Facilitating replication under stress: an oncogenic function of MYC?. Nature reviews. Cancer. 9(6). 441–444. 77 indexed citations
15.
Herold, Steffi, Andreas Hock, Barbara Herkert, et al.. (2008). Miz1 and HectH9 regulate the stability of the checkpoint protein, TopBP1. The EMBO Journal. 27(21). 2851–2861. 65 indexed citations
16.
Popov, Nikita, et al.. (2007). Fbw7 and Usp28 Regulate Myc Protein Stability in Response to DNA Damage. Cell Cycle. 6(19). 2327–2331. 102 indexed citations
17.
Walisko, Oliver, Zsuzsanna Izsvák, Kornélia Szabó, et al.. (2006). Sleeping Beauty transposase modulates cell-cycle progression through interaction with Miz-1. Proceedings of the National Academy of Sciences. 103(11). 4062–4067. 39 indexed citations
18.
Wanzel, Michael, Daniela Kleine‐Kohlbrecher, Steffi Herold, et al.. (2004). Akt and 14-3-3η regulate Miz1 to control cell-cycle arrest after DNA damage. Nature Cell Biology. 7(1). 30–41. 70 indexed citations
19.
Wanzel, Michael, Steffi Herold, & Martin Eilers. (2003). Transcriptional repression by Myc. Trends in Cell Biology. 13(3). 146–150. 161 indexed citations
20.
Herold, Steffi, Michael Wanzel, Vincent Beuger, et al.. (2002). Negative Regulation of the Mammalian UV Response by Myc through Association with Miz-1. Molecular Cell. 10(3). 509–521. 255 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jana Karásková Breakdown of academic impact, for papers by Peter J. Hurlin Breakdown of academic impact, for papers by Margareta Wilhelm Breakdown of academic impact, for papers by Micaela Quarto Breakdown of academic impact, for papers by Natalie Meyer Breakdown of academic impact, for papers by Wouter Nijkamp Breakdown of academic impact, for papers by Andrea Cocito Breakdown of academic impact, for papers by Abha Saxena Breakdown of academic impact, for papers by Anthony C. Liang Breakdown of academic impact, for papers by Brenda O’Connell
Rankless by CCL
2026